Live Breaking News & Updates on Electrical Remodeling

 E-Mail
(Boston) Atrial fibrillation (AF) is associated with a higher risk of complications including ischemic stroke, cognitive decline, heart failure, myocardial infarction and death. AF frequently is undetected until complications such as stroke or heart failure occur.
While the public and clinicians have an intense interest in detecting AF earlier, the most appropriate strategies to detect undiagnosed AF and medical prognosis and therapeutic implications of AF detected by screening are uncertain.
A new report led by Boston University School of Medicine (BUSM) researcher Emelia J. Benjamin, MD, ScM, builds upon a recently conducted National Heart, Lung, and Blood Institute s virtual workshop that focused on identifying key research priorities related to AF screening. ....

United States , Boston University , United Kingdom , Emeliaj Benjamin , Jeffrey Olgin , Stuart Connolly , Van Gelder , Bristol Myers Squibb , Bristol Meyers Squibb , Boehringer Ingelheim , Boston Biomedical Associates , Dutch Heart Foundation , Sanofi Aventis , European Union Horizon , Mcmaster University , Cardiology Research , German Center , Steering Committee Of The Fitbit Heart Study , Apple Inc , National Institute Of Diabetes , American Heart Association , Janssen Inc , Boston University School Of Medicine , British Heart Foundation , Oxford Biomedical Research Centre , Roivant Sciences ,